GlassScriptPhysician profile
Syed I Ahmed
NPI 1023005063
$18,642.72
in general payments reported to CMS, 2019-2025
50 companies · $1,690 in 2025
The $1,690 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,773 · 2020: $2,463 · 2021: $1,383 · 2022: $2,131 · 2023: $2,335 · 2024: $6,867 · 2025: $1,690.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,112 · Consulting Fee: $3,780.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,112.05 |
| Consulting Fee | $3,780.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $3,955.53 | 2023-2024 | Inpefa |
| Novartis Pharmaceuticals Corporation | $3,176.50 | 2019-2025 | |
| Medtronic, INC. | $1,441.29 | 2021-2025 | Corevalve Evolut R, Solitaire X |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,343.79 | 2019-2025 | Lifevest |
| Amgen INC. | $1,053.99 | 2019-2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $741.67 | 2019-2025 | Wainua, Farxiga |
| Medicure Pharma INC. | $639.64 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $545.32 | 2019-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $489.18 | 2021-2025 | Verquvo |
| Boston Scientific Corporation | $479.03 | 2021-2025 | Watchman Flx, Watchman Access System, Cds - Mct/Cem Monitoring |
| Janssen Pharmaceuticals, INC | $355.61 | 2019-2024 | Xarelto |
| Alnylam Pharmaceuticals INC. | $353.60 | 2020-2025 | Onpattro |
| E.R. Squibb & Sons, L.L.C. | $321.84 | 2021-2025 | Camzyos, Eliquis |
| Actelion Pharmaceuticals US, INC. | $292.53 | 2021-2025 | Opsumit, Uptravi |
| Medtronic Vascular, INC. | $280.78 | 2019-2020 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $277.61 | 2021-2025 | |
| Inari Medical, INC. | $276.06 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bayer Healthcare Pharmaceuticals INC. | $243.50 | 2021-2025 | |
| Scpharmaceuticals INC. | $229.02 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $216.48 | 2019-2024 | |
| Novo Nordisk INC | $208.86 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Covidien LP | $129.56 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $116.04 | 2019-2022 | |
| Cordis US Corp. | $107.24 | 2023-2025 | Mynx Control, Mynxgrip, Infiniti |
| Esperion Therapeutics, INC. | $103.05 | 2020-2021 | |
| Kiniksa Pharmaceuticals, LTD. | $100.56 | 2021-2023 | Arcalyst |
| Kiniksa Pharmaceuticals International, Plc | $95.48 | 2024 | Arcalyst |
| Biotronik INC. | $95.09 | 2021-2025 | Selectra |
| Abbott Laboratories | $94.27 | 2021-2025 | Cardiomems |
| Astellas Pharma US INC | $78.83 | 2019-2020 | |
| Amarin Pharma, INC. | $71.84 | 2019-2021 | |
| Kestra Medical Technology Services, INC. | $71.63 | 2022-2023 | Assure Wcd |
| Arbor Pharmaceuticals, INC. | $63.57 | 2019-2022 | |
| Abiomed | $59.72 | 2025 | |
| Daiichi Sankyo INC. | $57.83 | 2022-2025 | Injectafer |
| Cardiovascular Systems INC. | $55.77 | 2019-2021 | |
| Bridgebio Pharma, INC. | $54.98 | 2025 | Attruby |
| Acelrx Pharmaceuticals, INC. | $48.54 | 2021 | |
| Lundbeck LLC | $48.50 | 2019-2020 | |
| Irhythm Technologies, INC. | $45.74 | 2022-2023 | Zio Xt Patch |
| Elutia, INC. | $42.35 | 2019-2021 | |
| Inspire Medical Systems, INC. | $40.27 | 2024 | Inspire |
| Cardiva Medical, INC. | $21.50 | 2025 | Cardiva Vascade 6/7f Vcs |
| Vifor Pharma, INC. | $21.05 | 2019 | |
| Heartflow, INC. | $19.37 | 2025 | |
| Genzyme Corporation | $18.65 | 2019 | |
| Baxter Healthcare | $16.23 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Amryt Pharma Holdings LTD | $16.18 | 2023 | Juxtapid |
| Bardy Diagnostics, INC. | $16.09 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $10.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.